• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过定量组织学评估前列腺腺癌的预后因素。

Prognostic factors in prostatic adenocarcinoma assessed by means of quantitative histology.

作者信息

Eskelinen M, Lipponen P, Majapuro R, Syrjänen K

机构信息

Department of Surgery, University of Kuopio, Finland.

出版信息

Eur Urol. 1991;19(4):274-8. doi: 10.1159/000473642.

DOI:10.1159/000473642
PMID:1915532
Abstract

A series of 91 patients with prostatic adenocarcinoma were retrospectively followed up for an average of 15.6 years. The biopsies of the primary tumours were analysed using morphometry for six nuclear features, mitotic-activity index (MAI) and volume-corrected mitotic index. The histological grading of the tumours into three grades was done, and perineural infiltration and lymphatic infiltration were estimated. Clinical stage (p = 0.0137), lymphatic infiltration (p = 0.076) and histological grade (p = 0.1603) were the best predictors of survival in univariate analysis. A multiparameter analysis of progression in T category disclosed the MAI to be the most important single prognostic factor (p = 0.0276). Histological grade predicted progression in M category (p = 0.0166) in the same analysis. In intracapsular T1-T2 tumours, the SD of nuclear perimeter (p = 0.008) was shown by a multivariate analysis to be the most important predictor of progression. Progressed T1-T2 tumours had higher mitotic index values (p = 0.0215). The results advocate the use of mitotic indexes and morphometric measurements instead or as an adjunct of the conventional histological grading while predicting the progression of prostatic adenocarcinoma.

摘要

对91例前列腺腺癌患者进行了回顾性随访,平均随访时间为15.6年。采用形态计量学分析原发性肿瘤活检标本的六个核特征、有丝分裂活性指数(MAI)和体积校正有丝分裂指数。对肿瘤进行组织学分级,分为三级,并评估神经周围浸润和淋巴浸润情况。在单因素分析中,临床分期(p = 0.0137)、淋巴浸润(p = 0.076)和组织学分级(p = 0.1603)是生存的最佳预测因素。对T分期进展的多参数分析显示,MAI是最重要的单一预后因素(p = 0.0276)。在同一分析中,组织学分级可预测M分期的进展(p = 0.0166)。在包膜内T1-T2肿瘤中,多因素分析显示核周长标准差(p = 0.008)是进展的最重要预测因素。进展期T1-T2肿瘤的有丝分裂指数值较高(p = 0.0215)。结果表明,在预测前列腺腺癌进展时,可使用有丝分裂指数和形态计量学测量方法替代传统组织学分级或作为其辅助手段。

相似文献

1
Prognostic factors in prostatic adenocarcinoma assessed by means of quantitative histology.通过定量组织学评估前列腺腺癌的预后因素。
Eur Urol. 1991;19(4):274-8. doi: 10.1159/000473642.
2
The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
Int J Cancer. 1993 Oct 21;55(4):547-54. doi: 10.1002/ijc.2910550405.
3
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.前列腺腺癌的进展与生存:临床分期、Gleason分级、S期分数和DNA倍体的比较
Br J Cancer. 1994 Aug;70(2):309-14. doi: 10.1038/bjc.1994.298.
4
Mitotic activity and prognosis in prostatic adenocarcinoma.前列腺腺癌的有丝分裂活性与预后
Prostate. 1995 Feb;26(2):80-6. doi: 10.1002/pros.2990260204.
5
Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.细胞核形态测量及有丝分裂指数作为乳腺癌的预后因素
Eur J Surg. 1991 May;157(5):319-24.
6
Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.移行细胞膀胱癌的预后:一种用于改善预测的多变量预后评分
J Urol. 1991 Dec;146(6):1535-40. doi: 10.1016/s0022-5347(17)38159-4.
7
DNA ploidy, S phase fraction and G2 fraction as prognostic determinants in prostatic adenocarcinoma.DNA倍体、S期分数和G2期分数作为前列腺腺癌的预后决定因素。
Eur Urol. 1991;20(1):62-6. doi: 10.1159/000471663.
8
Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.经典预后因素、流式细胞术数据、核形态计量学变量及有丝分裂指数作为移行细胞膀胱癌的预测指标
Anticancer Res. 1991 Mar-Apr;11(2):911-6.
9
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.
Eur J Cancer. 1994;30A(12):1797-803. doi: 10.1016/0959-8049(94)e0159-2.
10
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
Anticancer Res. 1996 Jul-Aug;16(4A):2095-100.

引用本文的文献

1
Improved prediction of prostate cancer recurrence through systems pathology.通过系统病理学改善前列腺癌复发的预测
J Clin Invest. 2007 Jul;117(7):1876-83. doi: 10.1172/JCI31399.
2
Expression of retinoblastoma gene (Rb) protein in T12M0 prostatic adenocarcinoma.视网膜母细胞瘤基因(Rb)蛋白在T12M0前列腺腺癌中的表达
J Cancer Res Clin Oncol. 1995;121(7):429-33. doi: 10.1007/BF01212951.